Cara Therapeutics to Present at the Piper Jaffray 27th Annual Healthcare Conference

President and CEO of Cara Therapeutics, Inc. (NASDAQ:CARA) will present at the Piper Jaffray 27^th Annual Healthcare Conference on Wednesday, December 2, 2015.
According to the press release:

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.
[…] Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors.

Click here to read the full press release.